Autopsy report · NCT04614025
Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19
Cause of deathStaffing, sites or logistics
“The decision to bring the Study to early clinical readout came in response to COVID-19's evolution as a disease, and the significant changes in the standard of care, leading to an increase in the severity of conditions of the intubated patients.”
Life of this trial
- Ran for about 2 years 4 months before it stopped.
- 23 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Pluristem Ltd.
- Sponsor type
- Industry
- Conditions
- COVID; ARDS
- Interventions
- PLX-PAD
- Participants
- 23
- Sites
- 9
- Countries
- Germany, Israel
Trials that died the same way
- Diabetes Prevention With Lifestyle Intervention and Metformin Escalation
“COVID-19 led to changes in study design and an early end to data collection.” - A Comparison of the Post-C/S Analgesic Effects of Neuraxial Duramorph vs Bilateral TAP Block With Liposomal Bupivacaine
“Standard of Care changed due to COVID-19 and thus had to stop the study.” - Nasal Bridge Pressure Injury Prevention
“Evolution of the COVID19 pandemic with subsequent spread to all areas of clinical care severely affected the number of potential participants that were able to safely participate in the study.” - Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
“the study was started in the second half of the outbreak, and the number of qualifying COVID-19 patients decreased with the control of the epidemic so that we had to stop our trial before reaching the predefined sample size.” - Vitamin D Status and Bone Health of Older Adults in Care Facilities
“COVID-19, study status being reviewed on an ongoing basis.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.